Gene Therapy Communication: Use of a Needs Assessment to Drive Decision-AIDS for Gene Therapy for Rare Diseases (GENETX)
Condition(s):Sickle Cell DiseaseLast Updated:November 15, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):Sickle Cell DiseaseLast Updated:November 15, 2023Recruiting
Condition(s):Metastatic Oropharyngeal Carcinoma; Recurrent Oropharyngeal CarcinomaLast Updated:November 18, 2023Recruiting
Condition(s):Recurrent Acute Myeloid LeukemiaLast Updated:January 18, 2024Recruiting
Condition(s):Surgery; Postoperative Blood LossLast Updated:February 28, 2024Recruiting
Condition(s):Metastatic HER2-Negative Breast Carcinoma; Metastatic Triple-Negative Breast CarcinomaLast Updated:March 27, 2024Suspended
Condition(s):Clinical Stage III Cutaneous Melanoma AJCC v8; Clinical Stage IV Cutaneous Melanoma AJCC v8; Metastatic Melanoma; Refractory Melanoma; Unresectable MelanomaLast Updated:May 31, 2023Recruiting
Condition(s):ALL, Childhood; Acute Lymphoblastic LeukemiaLast Updated:August 14, 2023Recruiting
Condition(s):Head and Neck Cancer; Obstructive Sleep ApneaLast Updated:December 19, 2023Enrolling by invitation
Condition(s):Head and Neck Squamous Cell Carcinoma; Metastatic Head and Neck Squamous Cell Carcinoma; Stage IV Cutaneous Squamous Cell Carcinoma of the Head and NeckLast Updated:July 17, 2023Recruiting
Condition(s):Depressive DisorderLast Updated:October 10, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.